Utilize este identificador para referenciar este registo: http://hdl.handle.net/10316/91059
Título: Porous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery
Autor: Raquel Boia
Paulo A.N. Dias
Joana M. Martins
Caridad Galindo-Romero
Inês D. Aires
Manuel Vidal-Sanz
Marta Agudo-Barriuso
Hermínio C. de Sousa
António Francisco Ambrósio
Mara E.M. Braga
Ana Raquel Santiago
Palavras-chave: Biodegradable porous implants; Intraocular drug delivery; Poly (ε-caprolactone); Retina; Safety; Supercritical carbon dioxide foaming/mixing method
Data: 9-Nov-2019
Editora: Elsevier {BV}
Projeto: FCT, Portugal 
Centro2020 Regional Operational Programme 
Título da revista, periódico, livro ou evento: Journal of Contolled Release
Volume: 316
Local de edição ou do evento: The Boulevard Langford Lane Kidlington Oxford OX5 1GB United Kingdom
Resumo: This work reports the development of porous poly (ε-caprolactone) (PCL)-based intraocular implants, prepared by green supercritical carbon dioxide (scCO2) foaming/mixing method (SFM), to produce implants that degrade faster than typical slow-degrading PCL-based implants. The higher porosities and surface areas of these implants led to faster degradation rates at in vitro accelerated alkaline conditions than low porosity/surface area implants prepared by hot melting processing. These porous implants also presented distinct (faster) release rates of a test-drug (dexamethasone). Additionally, these porous devices did not cause cell death and did not reduce the number of neurons, indicating that are not toxic to retinal cells. We further explored the impact of PCL-based implant to the retina by in vivo evaluation and histological analysis. Implants were surgically inserted in the vitreous of Wistar rats, and their presence did not change the function, structure and anatomy of the retina. These devices demonstrated a good intraocular tolerance, further confirming their viability for prolonged drug delivery applications. Further comprehensive studies based on this promising preliminary assessment and proof-of-concept could enable its future translation to clinical protective strategies for retinal diseases.
URI: http://hdl.handle.net/10316/91059
ISSN: 01683659
DOI: 10.1016/j.jconrel.2019.09.023
Direitos: openAccess
Aparece nas coleções:I&D IBILI - Artigos em Revistas Internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato
porous p.pdf4.33 MBAdobe PDFVer/Abrir
Mostrar registo em formato completo

Visualizações de página

Visto em 24/set/2020

Google ScholarTM




Este registo está protegido por Licença Creative Commons Creative Commons